- Home
- MCRB vs EBMT Comparison
MCRB vs EBMT Comparison
Compare MCRB & EBMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MCRB | EBMT |
|---|---|---|
| Founded | 2010 | 1922 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 140.7M | 132.0M |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | MCRB | EBMT |
|---|---|---|
| Price | $15.92 | $20.23 |
| Analyst Decision | Hold | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $14.33 | N/A |
| AVG Volume (30 Days) | ★ 60.6K | 34.4K |
| Earning Date | 11-05-2025 | 01-22-2026 |
| Dividend Yield | N/A | ★ 2.90% |
| EPS Growth | N/A | ★ 58.15 |
| EPS | 0.62 | ★ 1.72 |
| Revenue | $351,000.00 | ★ $87,531,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $6.26 |
| P/E Ratio | $25.79 | ★ $11.61 |
| Revenue Growth | N/A | ★ 9.36 |
| 52 Week Low | $6.53 | $14.44 |
| 52 Week High | $29.98 | $20.40 |
Technical Indicators
Market Signals| Indicator | MCRB | EBMT |
|---|---|---|
| Relative Strength Index (RSI) | 51.12 | 64.86 |
| Support Level | $14.90 | $19.77 |
| Resistance Level | $16.00 | $20.40 |
| Average True Range (ATR) | 0.77 | 0.54 |
| MACD | 0.20 | -0.07 |
| Stochastic Oscillator | 82.78 | 85.80 |
Price Performance
Historical ComparisonAbout MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.
About EBMT Eagle Bancorp Montana Inc.
Eagle Bancorp Montana Inc operates as a bank holding company. It provides loan and deposit services. The company focuses on residential loans, commercial real estate loans, commercial loans, consumer loans, and home equity loan products. The bank also offers deposit accounts which include checking, savings, money market, individual retirement accounts, and certificates of deposit accounts. It is a diversified lender with a focus on residential mortgage loans, commercial real estate mortgage loans, commercial business loans, agricultural loans, and second mortgage/home equity loan products.